Avita Medical (ASX:AVH) said yesterday that it raised $9 million in a partially underwritten rights issue for its ReCell device, which is designed to use a patient’s own skin cells to treat burns, chronic wounds and skin defects. Avita, which has offices in Northridge, Calif., Cambridge, U.K. and Perth, Australia, said it issued nearly 100.2 million new shares in the […]
avitamedical
Avita taps IMS for BARDA economics study of ReCell
Avita Medical (ASX:AVH) said today it tapped health economics group IMS Health to join in an study of its ReCell regenerative medical device to evaluate its economic benefits when used at U.S. burn centers. The ReCell device is designed to use the patient’s own skin cells to treat a variety of skin issues, including burns, […]
HHS adds $8m, reups contract with Avita Medical
Avita Medical (ASX:AVH) said yesterday that the U.S. Department of Health and Human Services extended its contract with the company to the tune of an extra $8 million to support the U.S. market approval and launch of its ReCell autologous cell harvesting device. The ReCell device is designed to use the patient’s own skin cells […]
J&J investor relations veep Mehrotra retires, Wolk steps up | Personnel Moves June 22, 2016
J&J investor relations veep Mehrotra retires, Wolk steps up Johnson & Johnson (NYSE:JNJ) said today its 10-year vice president of investor relations Louise Mehrotra will retire, effective January 2017, to be replaced by Joseph Wolk, effective August 1. Wolk previously served as vice president of group finance for Johnson & Johnson’s pharmaceuticals deivision, and has […]
Avita Medical signs Malaysian distro deal with Mintcare
Avita Medical (ASX:AVH) said today it inked a distribution deal with Asia-Pacific specialized wound care product distributor Mintcare. Through the deal, Mintcare will distribute Avita’s wound care products throughout the Asia-Pacific region, with an initial focus on Malaysia, U.K.-based Avita Medical said. “The deal with Mintcare will give Avita Medical an active presence to deliver […]
Avita Medical inks China distro deal with Sinopharm
Avita Medical (ASX:AVH) said today it inked an exclusive Chinese distribution deal with Chinese healthcare group Sinopharm. The deal will grant Sinopharm’s MedTech subsidiary exclusive distribution rights for the range of Avita’s medical devices, including regenerative treatments for burns, chronic wounds and skin defects, Avita said. Shares in Avita rose approximately 2% in early day […]
Avita inks deal with EU distro deal with MSM Medical
Avita Medical (ASX:AVH) said today it inked a distribution deal with MSM Medical that will put the company in charge of selling its devices into the German, Austrian and Swiss markets. German-based MSM Medical sells advanced woudn care products in key german speaking territories, and has 8 offices in the country. The agreement came into effect […]
Avita Medical closes $2.6m respiratory biz sale
Avita Medical (ASX:AVH) said today that it closed the $2.64 million deal for its respiratory business with Medical Developments International. The division includes Avita’s Breath-A-Tech and Funhaler asthma spacers designed to optimize the use of medicinal puffers, marketed in Australian pharmacies. The buyout was announced in December 2015. “With the sale of the respiratory business, we […]
Avita Medical eyes Japan, South Korea for ReCell
Avita Medical (ASX:AVH) said yesterday it inked a distribution agreement with 2 companies to bring its ReCell to the Japanese and South Korean markets. The ReCell device is designed to use the patient’s own skin cells to treat a variety of skin issues, including burns, reconstructive and cosmetic procedures, the company said. “Japan and South […]
HeartWare taps ex-Medtronic exec Oesterle for board | Personnel Moves
HeartWare International (NSDQ:HTWR) is looking to get in on Dr. Stephen Oesterle, an Ex-Medtronic (NYSE:MDT) exec who moved to the venture capital firm New Enterprise Associates last Sept., saying this week that it expanded its board to accommodate Oesterle. Oesterle will officially come aboard on Jan. 18, and his appointment included an expansion to HeartWare’s board […]
Avita Medical sheds respiratory biz for $2.64m
Avita Medical (ASX:AVH) said today it sold its respiratory business to Medical Developments International for $2.64 million. The division includes Avita’s Breath-A-Tech and Funhaler asthma spacers designed to optimize the use of medicinal puffers, marketed in Australian pharmacies. “The sale of our respiratory business will enable Avita Medical to fully concentrate on our core regenerative […]